Pfizer PFE
NYSE PFE
$27.82 -0.43 (-1.52%)
At close: Aug 20, 2026 · 4:00 PM EDT

Pfizer (PFE) Consolidated Net Income (2009 - 2026)

Pfizer (PFE) posted quarterly Consolidated Net Income of -$13.0 million for Q1 2026, down 152.0% quarter-over-quarter from $25.0 million in Q2 2025.

Pfizer (PFE) Consolidated Net Income (2009 - 2026) Analysis & Trends

Pfizer (PFE) has reported Consolidated Net Income for 18 consecutive years, with -$13.0 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Consolidated Net Income changed N/A year-over-year to -$13.0 million; the TTM figure through Mar 2026 stood at $12.0 million (up 33.33% YoY), while the FY2025 annual figure was $25.0 million, up 127.27% from the prior year.
  • Consolidated Net Income declined to -$13.0 million in Q1 2026 per PFE's latest filing, from $25.0 million in the prior quarter.
  • Across five years, Consolidated Net Income topped out at $34.0 million in Q3 2022 and bottomed at -$26.0 million in Q4 2023.
  • Historically, Consolidated Net Income has averaged $1.4 million across 5 years, with a median of -$3.5 million in 2023.
  • Annual changes were most pronounced in 2022 — Consolidated Net Income slumped 1000.0% — and 2024, when it soared 950.0%.
  • Pfizer's Consolidated Net Income stood at $34.0 million in 2022, then plunged by 176.47% to -$26.0 million in 2023, then jumped by 69.23% to -$8.0 million in 2024, then surged by 412.5% to $25.0 million in 2025, then slumped by 152.0% to -$13.0 million in 2026.
  • Business Quant data shows PFE's Consolidated Net Income at -$13.0 million in Q1 2026, $25.0 million in Q2 2025, and -$8.0 million in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Johnson & Johnson 645.88 Bn 625.12 Bn 17.26 Bn 5.53 Bn
2 AbbVie 463.46 Bn 456.89 Bn 12.70 Bn 3.62 Bn
3 Merck 367.92 Bn 360.78 Bn 12.21 Bn -1.34 Bn
4 Novartis Ag 297.71 Bn 290.02 Bn 11.24 Bn 3.26 Bn
5 Astrazeneca 255.55 Bn 250.65 Bn 12.86 Bn 2.51 Bn
6 Amgen 234.52 Bn 220.53 Bn 7.24 Bn 2.38 Bn
7 Gilead Sciences 178.22 Bn 175.04 Bn 6.22 Bn -10.50 Bn
8 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn -238.00 Mn
9 Gsk 105.32 Bn 101.15 Bn 8.24 Bn 207.96 Mn
10 Sanofi 54.20 Bn 46.82 Bn 10.79 Bn 17.71 Bn

Historic Data

Download Data
DateValue
Jun 28, 2026 8.00 Mn
Mar 29, 2026 -13.00 Mn
Jun 29, 2025 25.00 Mn
Sep 29, 2024 -8.00 Mn
Jun 30, 2024 17.00 Mn
Mar 31, 2024 -5.00 Mn
Dec 31, 2023 -26.00 Mn
Jul 2, 2023 -2.00 Mn
Apr 2, 2023 1.00 Mn
Jul 3, 2022 34.00 Mn
Apr 3, 2022 -9.00 Mn
Oct 3, 2021 -248.00 Mn
Jul 4, 2021 -236.00 Mn
Apr 4, 2021 1.00 Mn
Sep 27, 2020 2.33 Bn
Jun 28, 2020 893.00 Mn
Mar 29, 2020 881.00 Mn
Dec 31, 2019 5.31 Bn
Sep 29, 2019 4.00 Mn
Dec 31, 2018 7.32 Bn